PTPN2 phosphatase deletion in T cells promotes anti‐tumour immunity and CAR T‐cell efficacy in solid tumours

Journal: The EMBO Journal

Published: 2019-12-05

DOI: 10.15252/embj.2019103637

Affiliations: 10

Authors: 19

Go to article
Institutions Share
Peter MacCallum Cancer Centre (Peter Mac), Australia 0.40
Sir Peter MacCallum Department of Oncology, UniMelb, Australia 0.11
Monash Biomedicine Discovery Institute (BDI), Monash University, Australia 0.10
Department of Biochemistry and Molecular Biology, Monash University, Australia 0.10
Department of Microbiology and Immunology, UniMelb, Australia 0.07
The Peter Doherty Institute for Infection and Immunity (Doherty Institute), Australia 0.07
Purdue Institute for Drug Discovery (PCDD), Purdue University, United States of America (USA) 0.05
Department of Medicinal Chemistry and Molecular Pharmacology (MCMP), Purdue University, United States of America (USA) 0.05
Telethon Kids Institute, Australia 0.03
The University of Western Australia (UWA), Australia 0.03

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER